EUVIMEDEUVIMED entdecken
Crossref

Distinct Activation and Functional Features of CD307c + T Lymphocytes in Peripheral Blood as Diagnostic and Prognostic Markers in Breast Cancer

Ziqi Xiong, Zhenxue Li, Zhao Guan, Sen Zhou, Yiming Zhao, Ming Zhao, Xiancan Ma, Yiming Gao, Zhonghui Zhang, Pingzhang Wang iD, Chen Liu iD

Immunology · 2025

DOI: 10.1111/imm.13960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology, 2025. Verfasst von Ziqi Xiong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Peking University People's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Lymphocyte Activation, Biomarkers, Tumor, CD8-Positive T-Lymphocytes. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Peking University People's Hospital Scientific Research Development Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to investigate the expression and role of CD307c in the breast cancer (BC) microenvironment, T lymphocytes of peripheral blood, particularly in BC patients at various stages, and assess its potential as a clinical diagnostic biomarker. Bioinformatics analysis was performed to investigate CD307c expression. As experimental validation, a total of 54 BC patients and 44 healthy controls (HCs) were enrolled. Flow cytometry was used to analyse CD307c expression in CD4 + and CD8 + T cells, alongside markers of T cell activation and function, such as PD‐1, Ki‐67, CD25, CD62L, GZMB and GZMK. Ex vivo T cell stimulation with anti‐CD3 and anti‐CD28 was performed to assess CD307c expression after activation. Statistical analyses, including receiver operating characteristic (ROC) curve analysis, were used to evaluate the diagnostic value of CD307c + T cell subsets. Bioinformatics analysis revealed that CD307c was significantly upregulated in BC tissues compared to adjacent normal tissues, and that CD307c was mainly expressed in lymphocytes, such as B cells, T reg s, CD8 + T cells and NKs in the tumour microenvironment. In peripheral blood, CD307c expression was significantly higher in CD4 + T cells compared to CD8 + T cells. CD307c + T cells exhibited elevated levels of Ki‐67, PD‐1, CD25 and CD62L, indicating increased activation and potential for immune exhaustion. Additionally, CD307c + CD8 + T cells showed higher expression of granzyme B (GZMB) and granzyme K (GZMK), markers of cytotoxicity. In BC patients, CD307c expression was significantly higher in both CD4 + and CD8 + T cells compared to HCs, and the proportion of CD307c + cells varied across cancer stages. CD307c expression in T lymphocytes is elevated in early‐stage BC. CD307c + T cells show enhanced activation, suggesting its potential role as a useful biomarker for early BC diagnosis and a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsLymphocyte ActivationBiomarkers, TumorCD8-Positive T-LymphocytesHumansFemaleMiddle AgedPrognosisTumor MicroenvironmentAdultAgedCD4-Positive T-Lymphocytes

Stichwörter der Autor:innen

CD307cT cellbreast cancergranzyme

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Peking University People's Hospital, Beijing, China.
  • Department of Clinical Laboratory, Dong E Hospital, Liaocheng, China.
  • Institute of Medical technology, Peking University Health Science Center, Beijing, China.
  • Department of Immunology, NHC Key Laboratory of Medical Immunology (Peking University), Medicine Innovation Center for Fundamental Research on Major Immunology-Related Diseases, School of Basic Medical Sciences, Peking…
  • Peking University Center for Human Disease Genomics, Peking University Health Science Center, Beijing, China.

ORCID-Profile: Pingzhang Wang, Chen Liu

Förderung

  • National Natural Science Foundation of China
  • Peking University People's Hospital Scientific Research Development Funds

Zitieren

APA

Xiong, Z., Li, Z., Guan, Z., Zhou, S., Zhao, Y., Zhao, M., Ma, X., Gao, Y., Zhang, Z., Wang, P., & Liu, C. (2025). Distinct Activation and Functional Features of CD307c + T Lymphocytes in Peripheral Blood as Diagnostic and Prognostic Markers in Breast Cancer. Immunology. https://doi.org/10.1111/imm.13960

Vancouver

Xiong Z, Li Z, Guan Z, Zhou S, Zhao Y, Zhao M, et al. Distinct Activation and Functional Features of CD307c + T Lymphocytes in Peripheral Blood as Diagnostic and Prognostic Markers in Breast Cancer. Immunology. 2025. doi:10.1111/imm.13960

BibTeX
@article{Xiong2025,
  author = {Xiong, Ziqi and Li, Zhenxue and Guan, Zhao and Zhou, Sen and Zhao, Yiming and Zhao, Ming and Ma, Xiancan and Gao, Yiming and Zhang, Zhonghui and Wang, Pingzhang and Liu, Chen},
  title = {Distinct Activation and Functional Features of CD307c + T Lymphocytes in Peripheral Blood as Diagnostic and Prognostic Markers in Breast Cancer},
  journal = {Immunology},
  year = {2025},
  doi = {10.1111/imm.13960}
}
Kostenlos starten →